KCTD14 and ovarian cancer: KCTD14 has not so far been investigated, and involvement in the onset and progression of cancer has not been documented, DB analysis suggests a potential protumor role in ovary cancers: COSMIC reports a CNV gain in 4.5% of ovary cancers and GENT2 a FC = 1.5 (p value < 0.001) in expression.